KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 99 filers reported holding KEROS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $697,949 | -20.1% | 21,893 | +0.7% | 0.01% | -25.0% |
| Q2 2023 | $873,674 | +8.8% | 21,744 | +15.6% | 0.01% | +14.3% |
| Q1 2023 | $802,974 | -10.5% | 18,805 | +0.6% | 0.01% | -12.5% |
| Q4 2022 | $897,350 | +70.0% | 18,687 | +33.3% | 0.01% | +60.0% |
| Q3 2022 | $528,000 | +34.0% | 14,022 | -1.7% | 0.01% | +25.0% |
| Q2 2022 | $394,000 | -70.6% | 14,262 | -42.2% | 0.00% | -73.3% |
| Q1 2022 | $1,342,000 | -15.3% | 24,671 | -8.9% | 0.02% | -16.7% |
| Q4 2021 | $1,584,000 | +40.1% | 27,071 | -5.3% | 0.02% | +63.6% |
| Q3 2021 | $1,131,000 | -13.2% | 28,599 | -6.8% | 0.01% | -8.3% |
| Q2 2021 | $1,303,000 | – | 30,687 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 407,633 | $12,995,340 | 5.15% |
| Opaleye Management Inc. | 360,400 | $11,489,552 | 3.74% |
| Parkman Healthcare Partners LLC | 298,475 | $9,515,383 | 1.74% |
| BRAIDWELL LP | 1,357,309 | $43,271,011 | 1.37% |
| First Light Asset Management, LLC | 421,438 | $13,435,443 | 1.28% |
| Orbimed Advisors | 1,514,734 | $48,289,720 | 1.03% |
| Yiheng Capital Management, L.P. | 554,151 | $17,666,334 | 0.90% |
| Nantahala Capital Management | 328,781 | $10,481,538 | 0.90% |
| DAFNA Capital Management LLC | 65,961 | $2,102,837 | 0.65% |
| EDBI Pte Ltd | 10,105 | $322,147 | 0.35% |